Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Oriental Culture | OCG | 17. avr 2025 | 3.56 | +0.28 |
Oriental Rise Holdings | ORIS | 17. avr 2025 | 0.94 | -2.19 |
Origin Agritech | SEED | 17. avr 2025 | 1.40 | +8.18 |
Origin Bancorp | OBK | 17. avr 2025 | 30.54 | +0.56 |
Origin Materials A | ORGN | 17. avr 2025 | 0.60 | +1.75 |
Orion Energy Systems | OESX | 17. avr 2025 | 0.71 | +0.23 |
Orion Group | ORN | 17. avr 2025 | 5.99 | +2.04 |
Orion Properties | ONL | 17. avr 2025 | 1.62 | +2.53 |
Orion S.A. | OEC | 17. avr 2025 | 11.91 | +1.62 |
Orix ADR | IX | 17. avr 2025 | 19.72 | +3.57 |
Orla Mining | ORLA | 17. avr 2025 | 11.27 | -1.14 |
Ormat Technologies | ORA | 17. avr 2025 | 71.59 | +1.76 |
Orrstown Financial Services | ORRF | 17. avr 2025 | 26.95 | +0.82 |
Orthofix Medical | OFIX | 17. avr 2025 | 13.03 | +0.54 |
OrthoPediatrics | KIDS | 17. avr 2025 | 21.00 | +1.99 |
Oruka Therapeutics | ORKA | 17. avr 2025 | 9.22 | +7.08 |
OS Therapies | OSTX | 17. avr 2025 | 1.53 | -2.55 |
Oscar Health A | OSCR | 17. avr 2025 | 12.03 | -2.59 |
Oshkosh | OSK | 17. avr 2025 | 84.50 | +0.02 |
OSI Systems | OSIS | 17. avr 2025 | 194.19 | +2.56 |
Osisko Development | ODV | 17. avr 2025 | 1.69 | -1.74 |
Osisko Gold Royalties | OR | 17. avr 2025 | 23.33 | -1.64 |
OSR Holdings | OSRH | 17. avr 2025 | 1.33 | 0.00 |
Ostin Technology Group | OST | 17. avr 2025 | 1.85 | -0.54 |
Otis Worldwide | OTIS | 17. avr 2025 | 98.52 | +1.80 |
Otter Tail | OTTR | 17. avr 2025 | 78.96 | +0.55 |
Ouster | OUST | 17. avr 2025 | 6.99 | +1.16 |
Outbrain | OB | 17. avr 2025 | 3.30 | +3.77 |
Outfront Media | OUT | 17. avr 2025 | 14.45 | +2.05 |
Outlook Therapeutics | OTLK | 17. avr 2025 | 1.45 | +5.84 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.